I
Last Price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | NOK381.89M |
EV | - |
Shares Outstanding | 78.90M |
Beta | 0.66 |
Industry | - |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
I
INIFY Laboratories AB
INIFY
Sector
Industry
CEO
Palm, Fredrik
Employees
Website
www.inify.comIPO Date
Headquarters
Hollandargatan 13, Stockholm, Stockholm County, 111 36, Sweden
INIFY Laboratories (INIFY) is considered a low volatility stock. It has a beta of 0.66, which means it typically moves 0.66 times as much as the broader market. Last updated: December 31, 2025 at 11:53 PM Eastern Time
The current INIFY Laboratories (INIFY) market capitalization is approximately NOK381.89M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, INIFY Laboratories's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:53 PM Eastern Time
INIFY Laboratories (INIFY) does not currently pay a dividend. Over the last twelve months (LTM), the company paid NOK0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, INIFY Laboratories (INIFY) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice.
Like other publicly traded stocks, INIFY Laboratories (INIFY) shares are bought and sold on stock exchanges such as OB and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for INIFY Laboratories (INIFY) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add INIFY to your watchlist.
INIFY Laboratories trades under the ticker symbol INIFY on the OB stock exchange. The ticker INIFY is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
INIFY Laboratories (INIFY) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest INIFY Laboratories (INIFY) stock peers based on overlapping products, services, and competitive dynamics:Diagnostyka (DIA)Voxel (VOX)Integrated Diagnostics Holdings (IDHC) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to INIFY Laboratories.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.